Aglaris
- Advanced Therapies Europe
Aglaris is a biotechnology company developing next-generation manufacturing technologies for cell and gene therapies. Its flagship system, the FACER Bioreactor, is a fully automated, closed, and modular platform designed to streamline therapeutic cell manufacturing—reducing manual operations, improving traceability, and enabling real-time remote control.
Aglaris collaborates with pharmaceutical companies, biotech firms, and academic hospitals across Europe to accelerate the industrialization and decentralization of cell therapy production. The company’s patented technology integrates smart sensors, single-use cartridges, and digital process control tools, offering an end-to-end solution from process development to GMP manufacturing.
By combining innovation, regulatory insight, and user-focused design, Aglaris aims to make advanced therapies more accessible, scalable, and affordable.
Address
Stevenage Bioscience Catalyst, Gunnels Wood RoadSG1 2FX
United Kingdom